Indication
SGLT2 inhibitor
1 clinical trial
1 product
1 drug
Clinical trial
The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics in Patients With Type 2 Diabetes and Obesity: A Prospective, Randomized, Open-label, Active Drug Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Product
HenagliflozinDrug
Metformin